User profiles for Arnaud Bourdin

arnaud bourdin

… of Montpellier, INSERM U1046, CNRS UMR 9214. Hôpital Arnaud de Villeneuve CHU …
Verified email at chu-montpellier.fr
Cited by 13717

Pulmonary arterial hypertension in patients treated by dasatinib

…, S Günther, L Savale, A Bergeron, A Bourdin… - Circulation, 2012 - Am Heart Assoc
Background— The French pulmonary hypertension (PH) registry allows the survey of
epidemiological trends. Isolated cases of precapillary PH have been reported in patients who have …

Integrated care pathways for airway diseases (AIRWAYS-ICPs)

…, S Bonini, LP Boulet, A Bourdin… - European …, 2014 - Eur Respiratory Soc
The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch
a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in …

Upper airway· 1: Allergic rhinitis and asthma: united disease through epithelial cells

A Bourdin, D Gras, I Vachier, P Chanez - Thorax, 2009 - thorax.bmj.com
The relationship between allergic rhinitis and asthma is now established, and most of the
clinical, epidemiological and biological data recommend integrated management. Epithelial …

[HTML][HTML] Oral glucocorticoid–sparing effect of benralizumab in severe asthma

P Nair, S Wenzel, KF Rabe, A Bourdin… - New England journal …, 2017 - Mass Medical Soc
Background Many patients with severe asthma rely on oral glucocorticoids to manage their
disease. We investigated whether benralizumab, a monoclonal antibody directed against the …

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

…, V Zindr, P Cerva, P Chanez, A Bourdin… - The lancet respiratory …, 2019 - thelancet.com
Background Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal
antibody that has been shown to safely reduce exacerbations and improve lung function for …

Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial

G Deslée, H Mal, H Dutau, A Bourdin, JM Vergnon… - Jama, 2016 - jamanetwork.com
Importance Therapeutic options for severe emphysema are limited. Lung volume reduction
using nitinol coils is a bronchoscopic intervention inducing regional parenchymal volume …

[HTML][HTML] Tezepelumab in adults and adolescents with severe, uncontrolled asthma

A Menzies-Gow, J Corren, A Bourdin… - … England Journal of …, 2021 - Mass Medical Soc
Background Tezepelumab is a human monoclonal antibody that blocks thymic stromal
lymphopoietin, an epithelial-cell–derived cytokine implicated in the pathogenesis of asthma. The …

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

…, A Chaouat, C Chabanne, A Bourdin… - European …, 2017 - Eur Respiratory Soc
Current European guidelines recommend periodic risk assessment for patients with
pulmonary arterial hypertension (PAH). The aim of our study was to determine the association …

Are overweight asthmatics more difficult to control?

P Saint‐Pierre, A Bourdin, P Chanez, JP Daures… - Allergy, 2006 - Wiley Online Library
The relationship between asthma and obesity appears to be quite complex. The aim of this
study was to assess the effect of excess weight on asthma control evolution in a cohort of …

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

…, JF Maspero, ID Pavord, A Papi, A Bourdin… - The Lancet …, 2022 - thelancet.com
Background Clinical trials have shown treatment benefits of dupilumab in patients with
uncontrolled asthma for up to 1 year. This study aimed to evaluate the long-term safety and …